Mélipharm
closedSterile medical devices for the treatment of acute and chronic wounds based on selected monofloral honey.
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Angel | ||
| Total Funding | 000k | ||
Related Content
Mélipharm is a French laboratory specializing in the development and commercialization of medical-grade honey for wound healing. Founded in 2009 by Professor Bernard Descottes, the company leverages over 25 years of clinical research initiated at the Limoges University Hospital. Professor Descottes, then head of the visceral surgery department, pioneered a protocol using honey to treat wounds, achieving a high success rate over thousands of patients. This extensive clinical experience forms the foundation of Mélipharm's product development.
The company operates in the medical device and dermo-cosmetics market, targeting healthcare establishments and consumers. Its business model centers on the production and sale of sterile, standardized honey-based treatments. Mélipharm generates revenue through two primary brands. The 'Melectis' range is designed for clinical settings like hospitals and nursing homes, addressing acute, chronic, and surgical wounds. The 'Melicare' line, developed in collaboration with midwives, focuses on postpartum care, including treating breastfeeding-related skin issues and is sold in pharmacies and used in maternity wards. Both product lines are classified as Class IIb medical devices, ensuring consistent and reproducible healing properties.
Mélipharm's core offering is a range of sterile healing gels made from a blend of selected monofloral honeys. These products provide antibacterial properties and promote healing through osmosis. The company has established a research and development unit in partnership with university laboratories to continuously validate the biological activities of its products and develop new applications. This has led to a second generation of patented products specific to different phases of the healing process. Recently, Mélipharm merged with Alvadiem, a specialist in apicultural dermo-cosmetics, to form the first French group dedicated to apicultural dermatology, combining medical devices with dermo-cosmetic care.
Keywords: medical honey, wound healing, apitherapy, dermo-cosmetics, medical devices, wound care, cicatrization, monofloral honey, antibacterial gels, postpartum care, surgical wound treatment, chronic wounds, Alvadiem, Melectis, Melicare, Bernard Descottes, skin healing, natural healthcare, Limoges University Hospital, apicultural dermatology